Abstract
The secondary metabolite monocerin is produced by the fungus Exserohilum rostratum, and in this study, efforts will be applied for obtaining a mutant strain able to produce this compound with higher yield than the wild strain.Due to the therapeutic potential in wounds and injuries, the monocerin will be incorporated in a pharmaceutical formulation, such as a cream, for topical application…